drugset
drugset / Trial / NCT01758744

Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1

NCT01758744 ↗

Phase 1 Completed 10 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelTreatment

Summary

An Open Label, Pilot Study Testing the Safety and Efficacy of Inhaled Treprostinil (Tyvaso®) in the Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)

Timeline

Start
2012-12
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil Other / unclassified — Inhaled

Indications

chronic obstructive pulmonary disease pulmonary hypertension